Signal: Novo partners with Valo Health for up to $2.7bn
Danish pharmaceutical company Novo Nordisk and US medtech start-up, Valo, have partnered to use Valo’s AI-powered human dataset to discover and develop new cardiometabolic treatments.
Sarah Brady
September 26, 2023